ISOBOL
Swiss trademark · 488513 · Word mark · Deleted
Register entry
- Registration number
- 488513
- Application number
- 07591/2001
- Status
- Deleted
- Type
- Word mark
- Filed
- Aug 2, 2001
- Registered
- Aug 30, 2001
- Published
- Oct 2, 2001
- Deleted
- Feb 25, 2022
- Reason
- Not renewed
- Language of procedure
- German
- Source
- Swissreg
Goods and services
Pharmaceuticals
Pharmazeutische Präparate zur Behandlung des Herz- und Kreislaufsystems sowie des Zentralnervensystems.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Feb 25, 2022
Deleted, not renewed
Published in Swissreg on 25.02.2022
- Oct 6, 2020
Agent’s address changed
- Representative
- Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49, Postfach, 8027 Zürich → Keller Schneider Patent- und Markenanwälte AG (Zürich), Beethovenstrasse 49, Postfach, 8027 Zürich
Published in Swissreg on 06.10.2020
- Apr 19, 2017
Agent’s address changed
- Representative
- Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49,, Postfach 2792, 8022 Zürich → Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49, Postfach, 8027 Zürich
Published in Swissreg on 19.04.2017
- Jun 22, 2011
Renewed
Published in Swissreg on 22.06.2011
- Jan 20, 2010
Agent entered
- Representative
- Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49,, Postfach 2792, 8022 Zürich
Published in Swissreg on 20.01.2010
- Feb 4, 2002
Partly deleted
- LGS
- 5, Pharmazeutische Produkte für den Menschen. → 5, Pharmazeutische Präparate zur Behandlung des Herz- und Kreislaufsystems sowie des Zentralnervensystems.
- International classification
- 5 → 5
Published in the SOGC no. 23 of 04.02.2002
- Oct 2, 2001
Registered
Published in the SOGC no. 190 of 02.10.2001
Parties
Holder
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.